They were taking subcutaneous semaglutide at doses ranging from 0.25 mg to 1 mg per week, which covers the standard semaglutide dosage range used clinically
In this exclusive report, Cure, a healthcare innovation ecosystem in New York City, and the Deerfield Institute unveil the results of a specialty physician survey, shedding light on their current prescribing of GLP-1RA medications, the challenges they face, and their expectations for future clinical applications of these drugs
This becomes their baseline for ongoing use
doi: 10.1186/s12929-017-0379-z 68 CardosoSCarvalhoCCorreiaSCSeicaRMMoreiraPI
Once the loading phase is complete, some researchers maintain effect with less frequent dosing (every 23 days), but initial daily administration is essential for onset
Missed weeks reset the signaling momentum